HEATERS FOR MEDICAL DEVICES
20230262872 · 2023-08-17
Inventors
Cpc classification
H05K1/0212
ELECTRICITY
B01L2200/16
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/10
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/147
PERFORMING OPERATIONS; TRANSPORTING
B01L7/52
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/12
PERFORMING OPERATIONS; TRANSPORTING
B01L3/50273
PERFORMING OPERATIONS; TRANSPORTING
H05K1/021
ELECTRICITY
G01K1/14
PHYSICS
B01L2200/14
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0475
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0677
PERFORMING OPERATIONS; TRANSPORTING
B01L3/5023
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502761
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01K1/14
PHYSICS
H05K7/20
ELECTRICITY
B01L3/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A medical device comprising a multilayer printed circuit board (PCB) comprising a heating element on an inner layer of the PCB; a single cell electrical power source to power the heating element; and a chamber adapted to contain a liquid, at least part of said chamber being defined by a thermally conductive material configured to provide a thermal transfer interface between the chamber and the PCB.
Claims
1. A medical device comprising: a multilayer printed circuit board (PCB) comprising a heating element on an inner layer of the PCB; a single cell electrical power source to power the heating element; and a chamber adapted to contain a liquid, at least part of said chamber being defined by a thermally conductive material configured to provide a thermal transfer interface between the chamber and the PCB.
2. A medical device according to claim 1, wherein the PCB also comprises control electronics for the device.
3. A medical device according to claim 1 or 2, wherein the heating element is on an inner layer of the PCB.
4. A medical device according to any of the preceding claims, wherein the heating element comprises a trace coil, e.g. a copper trace coil.
5. A medical device according to any of the preceding claims, wherein the thermally conductive material is a sheet of thermally conductive material, such as a foil, for example a metallic foil, e.g. aluminium foil.
6. A medical device according to any of the preceding claims, wherein the chamber comprises at least one substantially planar surface which is defined by the thermally conductive material.
7. A medical device according to any of the preceding claims, wherein the interface between the thermally conductive material and the PCB has a larger surface area than the area of the chamber defined by the thermally conductive material.
8. A medical device according to any of the preceding claims, which further comprises a temperature sensor thermally coupled to the chamber.
9. A medical device according to claim 8, wherein the temperature sensor is located on the PCB and a thermally conductive element, e.g. a copper pad, thermally couples the temperature sensor to the thermally conductive material.
10. A medical device according to any of the preceding claims, which further comprises a temperature controller, such as Proportional Integral (PI) or Proportional Integral Derivative (PID) controller.
11. A medical device of any of the preceding claims, which further comprises biasing means to urge the PCB into contact with the thermally conductive material.
12. A medical device according to claim 11, wherein the biasing means, e.g. a foam pad, is located between the PCB and a device casing within which the chamber and the PCB are housed; or the biasing means forms an integral part of the device casing.
13. A medical device according to any of the preceding claims, wherein the single cell power source is a AAA battery.
14. A medical device according to any of the preceding claims, wherein the electrical resistance of the PCB heating element is substantially the same as an internal electrical resistance of the power source.
15. A medical device according to any of the preceding claims, which comprises a plurality of chambers at least part of each of which is defined by a thermally conductive material.
16. A medical device according to any of the preceding claims, wherein the thermally conductive material defining at least part of the plurality of chambers is continuous between the plurality of chambers.
17. A medical device according to any of the preceding claims which is a diagnostic device or a medical delivery device.
18. A medical device according to any of the preceding claims wherein the chamber is a reaction chamber or a medicament chamber.
20. A medical device according to any of the preceding claims, wherein the chamber is a nucleic acid amplification reaction chamber.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0064] The invention will now be described, by way of example only, with reference to the accompanying drawings in which:
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072]
[0073]
[0074]
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
DETAILED DESCRIPTION
[0093] The embodiment of device according to the invention as shown in the drawings is a single use, i.e. one-shot, device for use in analysing a liquid sample by an analysis method which involves nucleic acid amplification and/or an immunoassay. The analysis may, without limitation, be performed for the purpose of detecting the presence of a pathogen and/or for the diagnosis, prophylaxis or monitoring of a disease or a diseased state, such as an infectious disease or cancer. The liquid sample may be, without limitation, a biological specimen, such as blood, synovial fluid, urine or cerebrospinal fluid, or derived from a biological specimen, such as a cervical smear sample, a blood serum or plasma sample, a swab sample such as a nasal, nasopharyngeal or throat swab sample, a stool sample, a sore sample or a sputum sample.
[0094] The analysis performed by the device may include nucleic acid amplification of a target nucleic acid, e.g. RNA or DNA, in the sample or derived from the sample, the nucleic acid amplification may be isothermal. Examples of isothermal amplification methods include loop-mediated isothermal amplification (LAMP), strand displacement amplification (SDA), helicase-dependent amplification (HDA), nicking enzyme amplification reaction (NEAR), nucleic acid sequence-based amplification (NASBA), signal mediated amplification of RNA technology (SMART), rolling circle amplification (RCA), isothermal multiple displacement amplification (IMDA), single primer isothermal amplification (SPIA), recombinase polymerase amplification (RPA), and polymerase spiral reaction (PSR). Examples of the nucleic acid analysis method that may be performed in the device are described in International Patent Applications WO2017/017424, WO2018/138499, WO2020/021272 and WO2021/148816. The analysis may involve depositing a volume of liquid sample into a sample receiving chamber of the device, from which at least part of the sample is then transferred to a reaction chamber where it is mixed with one or more reagents, and in which a nucleic acid amplification and/or immunoassay binding takes place. Subsequently, the sample may be conveyed to a test region, for example, to a lateral flow strip in the device.
[0095] In some embodiments the analysis process performed by the device may thus be considered to have three stages: mixing of reagent(s) with, or dissolving reagent in, at least part of the sample, the reacting the sample and reagent(s) and then the examination of the reacted sample.
[0096] With reference to
[0097] The upper casing half 1 also includes an aperture 10 for receiving a sample to be analysed. The aperture 10 is situated just beyond the end of a slot 12 through which a user contactable ridge 14 and hinged cap 16 of a lid 18 extends. The lid 18 is mounted on a guide rail 20 forming part of a chamber block 22, for linear movement along the elongate axis of the casing, and constitutes an actuating member.
[0098] The chamber block 22 also includes a sample receiving chamber 24 which is in register with the aperture 10, and an elongate channel forming a LFS chamber 26 for receiving the lateral flow strip 8. The LFS chamber can optionally be bonded to the upper casing half 1 to ensure a leak-tight seal, this may be achieved using an elastomer seal an ultrasonic weld, a labyrinth seal or a bead of elastomer sealant or adhesive. As can be seen from
[0099] One or both of the reaction chambers 36 and 38 contains one or more beads of reagent 35, and the underside of the chambers is closed and sealed by means of a piece of chamber foil 39.
[0100] The valve chamber 28 accommodates a valve rod 40 which is mounted on a valve actuator 42 for sliding movement along the underside of the guide 20. Situated beneath, and slidable relative to, the rod 40 and actuator 42 are a pair of parallel pistons 44 and 46 mounted on a piston actuator 48.
[0101] The piston actuator 48 has a lateral slot 50 into which an eccentric axial pin 52 of a rotary drive member 54 extends. In use, rotation of the rotary member 54 causes reciprocal movement first in one and then in the opposite direction, of the pistons 46 and 44 so that the latter perform two strokes within their chambers (i.e. cylinders). The central portion 55 of the slot 50 is arced on one side (see for example
[0102] The rotary member 54 is mounted atop a coiled torsion spring 56 which biases the rotary member in an anticlockwise direction, as viewed in
[0103] The rotary member 54 (and hence the piston actuator 48) and the valve actuator 42 are each coupled to the lid 18 by a pair of arced linkage arms 58 and 60 in a way described below. The arms 58 and 60 are mounted for lateral sliding movement on a chassis 62 which is snap fitted onto the casing half 1 and which also supports the chamber block 22. The chassis 62 includes a vertical boss 64 on which the spring 56 and rotary member 54 are mounted. The boss 64 also contains a retaining member 66 (in this case in the form of a thermoplastic catch) for pausing the rotation of the rotary member 54, and hence the movement of the pistons 44 and 46. Beneath the chassis 62, there is accommodated a printed circuit board (PCB) 68 and battery 70. Two separate heaters are printed onto the PCB 68, and their operation will be described below. A foam heater pad 72 is positioned under one of the heaters 1201 on the PCB, so as to urge that heater against the underside of the reaction chambers 36 and 38.
[0104] The interconnection between various components of the device will now be described.
[0105] With reference to
[0106] The spring 56 fits over the outside of the boss 64 and has a hooked lower end 96 which fits into a slot 98 in the chassis 62. The opposite end of the spring 56 is also provided with a hook 100 that locates in a slot 102 in the upper face of the rotary member 54. The spring 56 is preloaded so as to exert a torsional biasing force on the rotary member 54, so as to urge the latter to rotate in an anticlockwise direction.
[0107] As can be seen in
[0108] The underside of the flange 106 is provided with a number of formations used in the control of the operation of the device. More specifically, the flange has a dipped portion 118 that functions as a proximity switch actuator for an electro optical switch on the PCB 68. The actuator closes the switch when the rotary member 54 has finished its final rotation stage.
[0109] A first rib 120 extends generally radially from the body 104 and, in use, engages an abutment on the linkage arm 60 in the way described below. A second, slightly curved rib 122 is also provided on the underside of the flange 106 and engages an abutment on the arm 58, again as discussed below. A further radial rib 124 is provided in the top of the body portion 104 and, in use, engages the piston actuator 48 at the end of the operation of the device.
[0110] It will be appreciated that the spring 56 is situated on the outside of the boss 64, but within the body portion 104.
[0111] With reference to
[0112] The linkage arms 58 and 60 are of a similar construction to each other, save for the orientations of the lugs, and both have a pin 132 and 134 for engaging in a respective guide track on the underside of the lid 18 and a valve rib 136 and 138 which makes a camming engagement with the valve actuator 42 to move the valve forward as the arm is moved outwards, at 90° to the movement of the valve.
[0113] Each of the arms also includes a stop 140, 142 which in use abuts a respective one of the ribs on the underside of the flange 106 of the rotary member 54 to prevent rotation of the latter.
[0114] The stop 142, in use, engages the first rib 120 prior to the operation of the device. The stop 140 engages the second rib 122 to control the speed of the rotary member 54 as the abutments 110 and 112 approach the fingers 86 and 88.
[0115]
[0116] The pins 132 and 134 each extend into a respective guide way 150, 152 formed on the underside of the lid 18. As can be seen from
[0117] The cap 16 is connected to the rest of the lid 18 through a living hinge 154, and the lid is provided with ramps on either side, such as the ramp 156 which, in use, engage with flexible arms 609 on the chassis to provide the user with tactile feedback of the position reached during the forward sliding movement of the lid 18 and to lock the lid in its final position and prevent it being returned to its initial position. Switch tabs 158 extend down from the underside of the lid 18, and toggle activation of certain electrical components as the lid moves forward, as explained below.
[0118] The chamber block 22 of the device will now be described in detail with reference to
[0119] The chamber block 22 has several distinct zones for containing liquid at different stages of the procedure. The first of these is the sample receiving chamber 24 into which the liquid sample is placed; this chamber is most clearly visible in
[0120] Referring still to
[0121] As shown in
[0122] The valve chamber 28 receives the valve rod 40 and enables the sample receiving chamber 24, LFS chamber 26 and reaction chambers 36, 38 to be selectively fluidly connected to one another through linear movement of the valve rod 40 within the valve chamber 28 during operation of the device.
[0123] The sample receiving chamber 24 is directly fluidly connected to the valve chamber 28 through a valve port 311. The reaction chambers 36, 38 are each connected to a respective reaction chamber channel 313, each of which is in turn fluidly connected to the valve chamber 28 through a single (i.e. shared) reaction chamber channel port 315. The LFS chamber 26 is similarly connected to the valve chamber via an LFS channel 317, which is fluidly connected to the valve chamber 28 at an LFS channel entry port 319 and is fluidly connected to the LFS chamber 26 at an LFS channel exit port 321.
[0124] Cylindrical piston chambers 32 and 34 are positioned parallel to, and either side of, the valve chamber 28. As will be described below, each piston chamber is fluidly connected to a respective reaction chamber 36, 38 and is shaped to receive a respective piston.
[0125] As the lid 18 is moved between the series of positions illustrated in
[0126] The interconnection between the chambers of the chamber block 22 can be seen in the cross-sectional views of the diagnostic device shown in
[0127] Starting with
[0128] Moving on to
[0129] The valve rod 40, positioned in the valve chamber 28, is shaped such that it selectively connects the reaction chambers 36, 38 to the sample receiving chamber 24 or the LFS chamber 26 as it is linearly translated within the valve chamber 28 during operation of the device. In the illustrated example, the tip of the valve rod 40 has a ribbed/ridged seal that restricts the flow of liquid such that it can only flow in the region between two adjacent ribs/ridges, i.e. the ribs/ridges around the circumference of the valve rod 40 form a tight seal against the inner surface of the valve chamber 28. The seal could be made of a material such as rubber, and it may optionally be replaced with another sealing/coupling mechanism, such as a series of axially fixed 0-rings or similar.
[0130] In
[0131] The reaction chamber channel port 315 is also visible in
[0132] As mentioned above, the LFS chamber 26 is connected to the valve chamber 28 via the LFS channel 317. The LFS channel 317 is connected to the valve chamber 28 via the LFS channel entry port 319, and it is connected to the LFS chamber 26 via the LFS channel exit port 321. In the configuration in
[0133] An opening 501 is arranged at an end of the valve chamber 28. This allows air to discharge from the valve chamber 28 as the valve rod 40 is inserted into the valve chamber 28 during operation of the device.
[0134]
[0135] The operation of the device will now be described.
[0136] The initial state of the diagnostic device is shown in
[0137] In use, the sample is introduced into the sample receiving chamber 24, and the lid 18 is translated linearly forward from its first position (initial position) by a user of the device, thereby causing each of the linkage arm pins 132, 134 (and consequently the arms themselves) to be guided linearly outward (that is, away from a central longitudinal axis of the device) by the guide ways 150 and 152 at a predetermined stage during operation of the device. The first arm 60 and second arm 58 are retained in the device in such a way that they can only move linearly inward or outward, i.e. movement in a direction parallel to the longitudinal axis of the device is prevented.
[0138] Linear movement of the lid 18 is resisted by flexible arms 609 positioned on opposing sides of the chassis 62, which are initially in a neutral unbent position.
[0139] The valve rod 40 is initially in a maximally withdrawn position, as most visible in
[0140]
[0141] As seen in
[0142]
[0143] After, a sample, such as a blood or saliva sample taken from a patient (and optionally mixed with another liquid such as a buffer solution) has been loaded into the sample receiving chamber 24 by the user, the user then proceeds to push the lid 18 forward into the position shown in
[0144]
[0145] As seen in
[0146] Referring still to
[0147] As most visible in
[0148] As shown in
[0149] The user continues to move the lid 18 forward into the position shown in
[0150] As shown in
[0151] No further movement of the valve rod 40 occurs at this stage, such that the reaction chambers 36, 38 remain fluidly connected to the sample receiving chamber 24 (as shown in
[0152] Referring still to
[0153] The movement of the rotary member 54 in turns causes the pistons 44, 46 to fully retract/withdraw within the piston chambers 32 and 34 of the chamber block 22, as visible in
[0154] Due to the valve rod 40 being positioned to couple the reaction chambers 36, 38 to the sample receiving chamber 24, this in turn causes the liquid sample to be drawn from the sample receiving chamber 24 into the reaction chambers 36, 38 via the reaction chamber channels 313 and the reaction chamber channel port 315. The volume of liquid drawn into the reaction chambers 36, 38 corresponds to the volume of air that is drawn into the piston chambers 32 and 34, i.e. this is a predetermined volume.
[0155] In summary, the withdrawal of the pistons causes a pre-determined volume of the liquid sample to be drawn from the sample receiving chamber 24 into the valve chamber 28 through the valve port 311, and then into the reaction chambers 36, 38 through the reaction chamber channel port 315 and the reaction chamber channels 313.
[0156] At this stage, the beads 35, which are preferably lyophilised reagent beads or similar, mix with the liquid sample to form a solution (or mixture). Alternatively, the reagent may be in liquid form in the device or dried in situ rather than provided as a bead.
[0157] As shown in
[0158] A latch blockage 110, 112 on the rotary member 54 may abut against a rotary member blockage 86, 88 on the retaining member 66 at this stage, as shown in
[0159] After a brief pause (due to the click arms 609 clicking into the first grooves 801 on the lid 18 and causing the resistance of the lid 18 to increase), the user continues to move the lid 18 forward towards the position in
[0160] As shown in
[0161] As is visible in
[0162] At this stage, the click arms 609 are once again bent outward by the click arm ramps 156 on the lid 18 and continue to abut against the click arm ramps 156 and resist movement of the lid 18.
[0163] Meanwhile, the linearly outward movement of the second arm 58 also allows the rotary member 54 to slowly rotate anticlockwise with the motion of the second arm 58 due to the angled/sloped abutment between the rib 122 on the rotary member 54 and the stop 140 on the second arm 58, as shown in
[0164] The user then continues to move the lid 18 forward into the configuration shown in
[0165] At this stage, the cap 16 seals down on the sample receiving chamber 24, as shown in
[0166] As the lid 18 is moved forward, the pin 132 continues to follow the guide way 152 on the lid 18, which causes the second arm 58 to move further outward. This movement of the second arm 58 continues to push the valve rod 40 further into the valve chamber 28 into its final position (shown in
[0167] With the lid 18 in the closed second position (final position), the valve rod 40 is now fully inserted into the valve chamber 28 such that the reaction chamber channel port 315 and the LFS channel entry port 319 are now fully open and in fluidic communication with each other, thereby coupling the LFS chamber 26 to the reaction chambers 36, 38 via the reaction chamber channel port 315 and LFS channel 317 (and associated ports), as shown in
[0168] As shown in
[0169] A proximity sensor 1003, shown in
[0170] If the reagent heating element has not already been activated to heat the solution in the reaction chambers 36, 38 (for example when the activation switch 623 was initially closed) it would now be activated according to a timer or by the activation switch 623 reopening. The heater is controlled to a predefined temperature optimised for the performance of the reaction. When a certain temperature is reached a timer is then triggered which controls a heating period in the device during which a reaction occurs. The actual duration of the timer will depend on the diagnostic test being performed, but this could be on the order of 1-20 minutes for example.
[0171] When the reaction timer has completed it is turned off and the heating element on the tip 94 of the PCB is turned on.
[0172] As the heat from the heating element on the tip 94 of the PCB melts the bottom surface (melt surface) of the retaining member 66, the sloped engagement between the abutments 110 and 112 and the fingers 86 and 88 pushes the retaining member 66 down against the heating element. Thus, as the retaining member 66 melts and decreases in height, the resilient bias on the rotary member 54 provided by the spring 56 causes the sloped face to press the un-melted portion of the retaining member 66 against the heating element. The rotary member 54 rotates slightly as the retaining member 66 melts.
[0173] The retaining member 66 is preferably formed from a thermoplastic material with a low melting point such as polycaprolactone or a cyclic/cyclo olefin polymer or copolymer, and is selectively melted to mechanically release the rotary member 54 when required.
[0174] Once the retaining member 66 is sufficiently melted, the retaining member and the rotary member 54 disengage (due to the fingers 86 and 88 no longer being engaged with the abutments 110 and 112) and the rotary member 54 is free to rotate, as shown in
[0175] The views in
[0176] As most visible in
[0177] No further movement of the valve rod 40 occurs, such that the LFS chamber 26 remains fluidly connected to the reaction chambers 36, 38 via the valve chamber 28. Driving the pistons into the piston chambers 32 and 34 therefore results in pressure differential between the reaction chambers 36, 38 and the LFS chamber 26, which causes the heated solution in the reaction chambers 36, 38 to flow to the LFS chamber 26 (and so to the LFS 8). In the embodiment shown in
[0178] As the volume of all of the chambers is fixed and known and the magnitude of movement of the pistons 44 and 46 are predetermined by the arrangement of the rotary member 54 and pistons, the volume of solution that is transferred from the reaction chambers 36, 38 to the LFS chamber 26 is also a predetermined quantity.
[0179] Rotation of the rotary member 54 additionally causes the proximity switch actuator 118 on the rotary member 54 to obscure the proximity sensor 1003 on the PCB 68, thereby reflecting light emitted by the proximity sensor 1003 back onto the proximity sensor 1003. The resulting signal from the proximity sensor 1003 indicates that the solution has been successfully moved to the LFS 8, which triggers the start of a timer while the results develop. Once the timer is complete, an indication may be displayed to the user, such as a blue LED being activated (e.g. instead of a green pulsing LED as described earlier). The actual duration of the timer will depend on the diagnostic test being performed, but this could be on the order of 1-20 minutes for example.
[0180] Upon receiving the indication that the timer (and therefore the test) is complete, the user can read the LFS 8 through the label 6 to obtain the test result. The LFS 8 is a testing strip and may typically comprise printed lines or an affinity bioreagent such as an oligonucleotide or an antibody such that it interacts with the reagent solution from the reaction chambers in a known way. If a biomolecule to be detected was present in the sample, the LFS 8 provides a visual indication at the relevant line which can be read through the label 6.
[0181] As described above, both the reagent solution and the retaining member 66 are heated by heating elements on the PCB 68.
[0182] The position of the reagent heating element 1201 can be seen in
[0183] As visible from
[0184] The heater foam pad 72 is positioned below the reagent heating element 1201 between the lower casing half 2 and the PCB 68. While the lower casing half 2 and/or the chassis 62 may be shaped to guide the PCB 68 into the correct position, the PCB 68 is preferably a floating component rather than fixed to the casing or chassis. The PCB 68, and therefore the reagent heating element 1201, are pushed against the chamber foil 39 by the heater foam 72, thereby ensuring good thermal contact between the reagent heating element 1201 and the chamber foil 39 regardless of manufacturing tolerances.
[0185] A temperature sensor 1203 is positioned on PCB 68 in proximity to the reagent heating element 1201. As shown in
[0186] The heater coils of the reagent heating element 1201 are designed to reach past the nominal internal edge of the reaction chamber to also cover the area of the chamber foil 39 on either side where the foil is supported by the chamber block 22. This removes the requirement to have a well-supported or flat surface to the chamber foil 39 in the area directly below the chamber to attain good heating performance, as the heat transfers laterally/sideways across the chamber foil 39.
[0187] As shown in
[0188] In the exemplary device shown in
[0189] Referring now to
[0190] As is clear from the above description, the diagnostic device according to the present invention provides a simple, quick, and effective way to test patients for a disease. A sample is taken from the user and placed in the sample receiving chamber 24 (potentially mixed with another liquid such as a buffer solution). The sample could be taken by the patient, or by another person such as a medical professional.
[0191] Once the sample has been placed in the sample receiving chamber 24, the user of the device (which could be the patient or another person such as a medical professional) actuates the lid 18 forward to the position shown in
[0192] The user then continues to actuate the lid 18 forward to the position shown in
[0193] A timer in the device is then further activated by the proximity sensor 1003 to countdown to completion of the analysis, at which point an indication is displayed to the user to indicate that the analysis is complete and the result can be read from the LFS 8. The diagnostic device can then be disposed of appropriately, for example it might be treated as medical waste and incinerated.
[0194] Using this device means there is no need to send a liquid sample to a laboratory, meaning the test can be performed immediately once the sample has been taken. As the patient and the device are preferably in the same location, the test result can be communicated to the patient as soon as the device indicates the test has been completed. As the device controls the flow and heating of liquids (i.e. a predetermined volume of the sample and reagent solutions is transferred between the chambers, and the reagent solution is heated to a predetermined temperature), the test can be performed accurately with minimal user input. The nature of the arms 58 and 60 and the guide ways 150 and 152 means that the device is not particularly sensitive to the speed at which the lid 18 is moved, meaning the device requires very little skill to operate and could be used outside of dedicated testing or healthcare settings or for at-home testing by distributing it to a patient, for example through the post.
[0195] Additionally, as there are no complex components such as motors or similar driving the pistons etc, the device can be manufactured relatively cheaply, making it ideal for mass testing, such as during a pandemic or for widespread seasonal infections such as influenza. Many of the parts can be made of relatively cheap and easily obtainable plastics, and the PCB 68 can be mass produced at relatively low cost. In addition, testing using the diagnostic device of the present invention does not require skilled laboratory technicians or expensive laboratory equipment.
[0196] The diagnostic device can be adapted to test for different diseases as needed by selecting an appropriate reagent bead and lateral flow strip and programming the PCB 68 (or more specifically, a processing device of the PCB 68) with suitable timings and heating temperatures (e.g. reagent heating temperature and/or duration). In addition, the volume of fluid drawn into the chambers can be adjusted by selecting appropriate values for the piston size and magnitude of movement. The device could also be used for testing purposes other than diseases, for example other biological and chemical tests.
[0197] While the diagnostic device described above illustrates one example of the invention, it should be understood that alternative embodiments are also envisaged, and this exemplary device should not be construed as limiting. Individual features of the diagnostic device described above may be used independently in other embodiments of the device of the invention.
[0198] For example, the device could be modified to have separate bead chambers and reaction chambers. In addition, alternative cam mechanisms which allow for additional/different sequencing of the filling/emptying of chambers could be implemented, such as designs involving injecting liquid into the reaction/bead chamber under positive pressure for enhanced mixing of the reagents and the liquid sample.
[0199] Other potential variations include designs where the valve is formed from two parallel shafts either side of a central piston, which may allow for an improved layout with regard to dead volumes/functionality.
[0200] In addition, the device might be modified such that the sequence of fluid transfers allows for the sample to be preheated in the sample receiving chamber or another chamber prior to mixing with the reagents.
[0201] In the embodiment described above once the analysis is complete the result can be read from a lateral flow strip. However other methods of presenting the results of the analysis are envisaged, such methods preferably report the presence of the biomolecule in the sample differentially from other components in a sample and from reagents. The detection method may be qualitative or quantitative. The detection may give a visual read out of the results as with the lateral flow strip, it may for example be colorimetric or fluorometric. Alternatively, the presence of a biomolecule may be detected electrically, such as by a change in impedence or a change in conductimetric, amperometric, voltammetric or potentiometric signal.
[0202] The device may be used for simultaneously analysing a plurality of biomolecules in a liquid sample, it may also be used for performing a process control during the analysis.
[0203] One skilled in the art will understand that other modifications could also be made, such as using a different battery/cell, using multiple printed circuit boards in place of a single printed circuit board assembly, using a single reaction chamber and/or a single piston, combining/swapping one or more of the functions of the first and second arm, adding additional arms etc. These variations are merely given as examples, and numerous other variations are also possible without departing from the scope of the invention.
Example 1
Detection of Genomic RNA from the Pathogen SARS-CoV-2 In a Liquid Sample
[0204] This example describes the use of devices and methods according to the invention for detecting the presence of SARS-CoV-2 which is a single-stranded RNA virus and causes coronavirus disease 2019 (COVID-19).
[0205] One device was loaded and actuated as described above with reference to
[0206] Throughout the specification and the claims which follow, unless the context requires otherwise, the word ‘comprise’, and variations such as ‘comprises’ and ‘comprising’, will be understood to imply the inclusion of a stated integer, step, group of integers or group of steps but not to the exclusion of any other integer, step, group of integers or group of steps. All patents and patent applications referred to herein are incorporated by reference in their entirety.
[0207] Further aspects of the invention include the following:
[0208] 1. A device for use in the analysis of a biomolecule in a liquid sample, the device having a plurality of zones for accommodating at least part of the liquid sample, transfer means for transferring at least part of the liquid sample from one to another of said zones along a respective flow path, mechanically powered drive means for operating the transfer means, flow control means for selectively opening one or more flow path between the zones, and a common actuating member which sequentially controls both the mechanically powered drive means and the flow control means to achieve transfer of at least part of the liquid sample between said zones.
[0209] 2. A device according to aspect 1, in which the drive means comprises a rotary member.
[0210] 3. A device according to aspect 2, in which the transfer means has a displacement member which is linearly movable, the rotary member being coupled to the transfer means by a linkage which converts rotational movement of the rotary member into linear movement of the displacement member, to cause one or more transfers between zones under the power of the drive means.
[0211] 4. A device according to aspect 3, in which the displacement member comprises at least one piston.
[0212] 5. A device according to aspect 4, in which the piston is one of a pair of such pistons, each movable in a respective cylindrical piston chamber.
[0213] 6. A device according to any of the preceding aspects, in which the drive means includes biasing means for storing mechanical energy for powering the drive means.
[0214] 7. A device according to aspect 6, in which the biasing means comprises a mechanical spring.
[0215] 8. A device according to aspect 7, in which, the biasing means comprises a torsion spring.
[0216] 9. A device according to any of aspects 6 to 8, in which the biasing means is preloaded.
[0217] 10. A device according to aspect 9 as dependent from any of aspects 3 to 8, in which the biasing means is preloaded with sufficient energy to cause movement of the displacement member along two, opposite linear strokes.
[0218] 11. A device according to any of the preceding aspects, in which the plurality of zones comprises a sample receiving means through which the sample is introduced into the device, a reaction chamber in which the sample undergoes one or more reactions specific to the analysis and a test region for subsequently analysing the reacted sample.
[0219] 12. A device according to aspect 11, in which the sample receiving means comprises a sample receiving chamber.
[0220] 13. A device according to aspect 12, which includes a cap or cover for closing the sample receiving chamber during the operation of the device.
[0221] 14. A device according to aspect 13, in which the common actuating member comprises the cap or cover for closing the sample receiving chamber.
[0222] 15. A device according to any of the preceding aspects, in which the device includes a heater for heating at least part of the liquid sample.
[0223] 16. A device according to aspect 15, in which the heater is an electric heater forming part of a printed circuit board (PCB).
[0224] 17. A device according to aspect 16 in which the PCB also carries control electronics for the device.
[0225] 18. A device according to any of aspects 15 to 17, in which the heater is thermally coupled to a reaction chamber and the analysis includes the step of heating at least part of the liquid sample in the reaction chamber.
[0226] 19. A device according to aspect 18, in which the reaction chamber is at least partially defined by a thermally conductive material, such as a foil, for example a metallic foil, e.g. aluminium foil.
[0227] 20. A device according to aspect 19, in which the device includes biasing means for urging the heater against the thermally conductive material.
[0228] 21. A device according to any of aspects 18 to 20, in which the heater and the thermally conductive material extend beyond the reaction chamber.
[0229] 22. A device according to any of aspects 18 to 21, in which the device includes a temperature sensor thermally coupled to the reaction chamber.
[0230] 23. A device according to any of the preceding aspects, in which the device includes retaining means for temporarily interrupting the operation of the drive means so as to delay the completion of the operation of the transfer means for a period.
[0231] 24. A device according to aspect 23, in which the retaining means comprises a thermoplastic retaining member for engaging, and acting as a stop to, the drive means and a heater for heating the thermoplastic retaining member, causing the latter to soften or melt, so as to release the drive means therefrom after said period.
[0232] 25. A device according to aspect 24, in which the retaining means comprises a thermoplastic catch.
[0233] 26. A device according to any of the preceding aspects, in which the actuating member is movable along a single actuating member stroke, the device being arranged for this single movement to cause the device to perform a predetermined sequence of operations to achieve said analysis of the sample.
[0234] 27. A device according to aspect 26, in which the actuating member is linearly movable, to perform said stroke.
[0235] 28. A device according to any of the preceding aspects, in which the actuating member is manually operable by a user of the device.
[0236] 29. A device according to any of aspects 11 to 28, in which the sequence of operations of the device comprises the transfer of at least part of the liquid sample from the sample receiving means to the reaction chamber along a flow path through the flow control means, where it undergoes one or more reactions and subsequently transferring reacted sample from the reaction chamber to the test region along another path through the flow control means.
[0237] 30. A device according to any of the preceding aspects, in which the flow control means comprises a valve.
[0238] 31. A device according to aspect 30, in which the valve includes a rod linearly movable in a valve chamber to bring selective pairs of ports into fluid communication, so as to create said one or more flow paths.
[0239] 32. A device according to any of aspects 11 to 31, in which the device includes a detent that resists movement of the actuating member beyond a position part way along said stroke, at which position a flow path has been established by the flow control means between the sample receiving means and the reaction chamber and the operation of the transfer means to transfer the sample into the reaction chamber has been triggered, but before completion of the stroke at which position a flow path between the reaction chamber and the test region has been established by the flow control means.
[0240] 33. A device according to any of aspects 11 to 32, in which the test region comprises a lateral flow strip.
[0241] 34. A device according to any of the preceding aspects, in which the device includes monitoring means for monitoring the operation of the device and providing a warning if incorrect operation is detected.
[0242] 35. A device according to any of the preceding aspects which is a disposable, one shot device.
[0243] 36. A method for the analysis of a biomolecule in a liquid sample comprising introducing the liquid sample into a device according to any of the preceding aspects and actuating the common actuating member.
[0244] 37. A device comprising: [0245] a resiliently biased latch member; [0246] a thermoplastic retaining member having at least one engagement surface configured to engage with and act as a stop to the latch member; and [0247] a heating member positioned in proximity to the thermoplastic retaining member, [0248] wherein activation of the heating member softens at least a portion of the thermoplastic retaining member to release the latch member.
[0249] 38. The device according to aspect 37, wherein the engagement surface is sloped such that the engagement between the engagement surface and the latch member presses the thermoplastic retaining member towards the heating member.
[0250] 39. The device according to aspect 37 or 38, wherein the latch member comprises a sloped engagement surface such that the engagement between the engagement surface of the thermoplastic retaining member and the latch member presses the thermoplastic retaining member towards the heating member.
[0251] 40. The device according to any of aspects 37 to 39, wherein the thermoplastic retaining member has a softening or melting temperature of between 40° C. and 150° C.
[0252] 41. The device according to any of aspects 37 to 40, wherein the thermoplastic retaining member comprises polycaprolactone or a cyclic/cyclo olefin polymer or copolymer.
[0253] 42. The device according to any of aspects 37 to 41, wherein the heating member is an element of a printed circuit board (PCB).
[0254] 43. The device according to any of aspects 37 to 42, further comprising a temperature sensor in thermal contact with the PCB.
[0255] 44. The device according to any of aspects 37 to 43, wherein the device is configured to soften the thermoplastic retaining member and thereby to release the latch member after a controlled period.
[0256] 45. The device according to any of aspects 37 to 44, wherein release of the latch member releases stored mechanical energy, for example stored mechanical energy in a preloaded biasing means such as a mechanical spring, e.g. a torsion spring.
[0257] 46. The device according to any of aspects 37 to 45, wherein release of the latch member causes a drive means to transfer a liquid.
[0258] 47. The device according to aspect 46, wherein the drive means transfers the liquid between different zones in the device.
[0259] 48. A medical device comprising: [0260] a chamber adapted to contain a liquid, at least part of said chamber being defined by a thermally conductive material; and [0261] a multilayer printed circuit board (PCB) comprising a heater; [0262] wherein the thermally conductive material forms an interface between the chamber and the PCB.
[0263] 49. A medical device according to aspect 48, wherein the PCB also comprises control electronics for the device.
[0264] 50. The medical device according to aspect 48 or 49, wherein the heater is on an inner layer of the PCB.
[0265] 51. The medical device according to any of aspects 48 to 50, wherein the heater comprises a trace coil, e.g. a copper trace coil.
[0266] 52. The medical device according to any of aspects 48 to 51, wherein the thermally conductive material is a sheet of thermally conductive material, such as a foil, for example a metallic foil, e.g. aluminium foil.
[0267] 53. The medical device according to any of aspects 48 to 52, wherein the chamber comprises at least one substantially planar surface which is defined by the thermally conductive material.
[0268] 54. The medical device according to any of aspects 48 to 53, wherein the interface between the thermally conductive material and the PCB has a larger surface area than the area of the chamber defined by the thermally conductive material.
[0269] 55. The medical device according to any of aspects 48 to 54, which further comprises a temperature sensor thermally coupled to the chamber.
[0270] 56. The medical device according to aspect 55, wherein the temperature sensor is located on the PCB and a thermally conductive element, e.g. a copper pad, thermally couples the temperature sensor to the thermally conductive material.
[0271] 57. The medical device according to any of aspects 48 to 56, which further comprises a temperature controller, such as Proportional Integral (PI) or Proportional Integral Derivative (PID) controller.
[0272] 58. The medical device of any of aspects 48 to 57, which further comprises biasing means to urge the PCB into contact with the thermally conductive material.
[0273] 59. The medical device according to aspect 58, wherein the biasing means, e.g. a foam pad, is located between the PCB and a device casing within which the chamber and the PCB are housed; or the biasing means forms an integral part of the device casing.
[0274] 60. The medical device according to any of aspects 48 to 59, which further comprises an electrical power source, such as a battery or cell, to power the heater.
[0275] 61. The medical device according to aspect 49 or any of the aspects 50 to 60 as dependent from aspect 49, wherein the electrical resistance of the PCB trace coil is substantially the same as an internal electrical resistance of the power source.
[0276] 62. The medical device according to any of aspects 48 to 61, which comprises a plurality of chambers at least part of each of which is defined by a thermally conductive material.
[0277] 63. The medical device according to any of aspects 48 to 62, wherein the thermally conductive material defining at least part of the plurality of chambers is continuous between the plurality of chambers.
[0278] 64. The medical device according to any of aspects 48 to 63 which is a diagnostic device.
[0279] 65. The medical device according to any of aspects 48 to 64 wherein the chamber is a reaction chamber or a medicament chamber.
[0280] 66. The medical device according to any of aspects 48 to 65, wherein the chamber is a nucleic acid amplification reaction chamber.